Literature DB >> 17825254

Activation of toll-like receptor 4 modulates vascular endothelial growth factor synthesis through prostacyclin-IP signaling.

Dae-Weon Park1, Kheewoong Baek, Jin-Gu Lee, Yun-Ki Park, Jung-Hye Kim, Jae-Ryong Kim, Suk-Hwan Baek.   

Abstract

In this study, we show that activation of toll-like receptor (TLR)4 by lipopolysaccharide (LPS) induces cyclooxygenase-2 (COX-2) expression, which results in prostaglandin (PG)I2 formation in macrophages. The LPS-stimulated COX-2 expression and PGI2 release were accompanied by production of the potent angiogenic cytokine, vascular endothelial growth factor (VEGF), and these effects were suppressed by NS-398, which is a COX-2 inhibitor. Direct addition of iloprost (an analogue of PGI2) for IP receptor also induced the production of VEGF, whereas DP, FP, and TP receptor agonists did not. Inhibition of IP protein expression by micro interfering RNA blocked LPS-induced VEGF production. Additionally, macrophages transiently caused Akt phosphorylation after stimulation with LPS, and inhibition of Akt phosphorylation blocked the production of VEGF and COX-2 expression in response to LPS. Overall, this study demonstrated that engagement of TLR4 with LPS induces production of PGI2 via Akt and generates VEGF through IP receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825254     DOI: 10.1016/j.bbrc.2007.08.119

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Does toll-like receptor-3 (TLR-3) have any role in Indian AMD phenotype?

Authors:  Neel Kamal Sharma; Kaushal Sharma; Amod Gupta; Sudesh Prabhakar; Ramandeep Singh; Pawan Kumar Gupta; Akshay Anand
Journal:  Mol Cell Biochem       Date:  2014-03-30       Impact factor: 3.396

2.  Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) rat.

Authors:  Xiang Shan Ren; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Norihide Yoneda; Zhen Hua Lin; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

3.  Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis.

Authors:  Nicholas A Manieri; Madison R Mack; Molly D Himmelrich; Daniel L Worthley; Elaine M Hanson; Lars Eckmann; Timothy C Wang; Thaddeus S Stappenbeck
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

4.  Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples.

Authors:  Youngeun Cho; Jie Jin Wang; Emily Y Chew; Frederick L Ferris; Paul Mitchell; Chi-Chao Chan; Jingsheng Tuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

5.  High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5.

Authors:  Jong-Jer Lee; Chang-Chun Hsiao; I-Hui Yang; Ming-Huei Chou; Chia-Lin Wu; Yin-Chu Wei; Chih-Hsin Chen; Jiin-Haur Chuang
Journal:  Mol Vis       Date:  2012-04-05       Impact factor: 2.367

6.  Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats.

Authors:  Gisele F Bomfim; Rosangela A Dos Santos; Maria Aparecida Oliveira; Fernanda R Giachini; Eliana H Akamine; Rita C Tostes; Zuleica B Fortes; R Clinton Webb; Maria Helena C Carvalho
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

7.  Suitability of endogenous reference genes for gene expression studies with human intraocular endothelial cells.

Authors:  Ruoxin Wei; Elizabeth Anne Stewart; Winfried M Amoaku
Journal:  BMC Res Notes       Date:  2013-02-04

Review 8.  AMD Genetics in India: The Missing Links.

Authors:  Akshay Anand; Kaushal Sharma; Suresh K Sharma; Ramandeep Singh; Neel K Sharma; Keshava Prasad
Journal:  Front Aging Neurosci       Date:  2016-05-23       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.